Regional News

TuanChe Outlines Preliminary Plan for Its EV Business

BEIJING, Jan. 21, 2022 /PRNewswire/ -- TuanChe Limited ("TuanChe" or "the Company") (NASDAQ: TC), a leading integrated automotive marketplace inChina, today revealed its preliminary plan for the new electric vehicle (EV) business. "We seek to differentiate our EV models from other models on the m...

2022-01-21 18:00 3617

CASETiFY Collaborates with Peanuts to Introduce a Snoopy and Friends-Inspired Collection

LOS ANGELES, Jan. 21, 2022 /PRNewswire/ -- Today, the custom lifestyle brand CASETiFY announced its very first collaboration with Peanuts. In a special collection that combines CASETiFY's knack for design and protection with the incomparable charm ofCharlie Brown, Snoopy, and the rest of the Pean...

2022-01-21 16:00 3466

Sustainable aircraft "life cycle" service centre landed in Shuangliu, Chengdu, China

CHENGDU, China, Jan. 21, 2022 /PRNewswire/ -- Airbus has signed a Memorandum Of Understanding (MOU) with the city ofChengdu and Tarmac Aerosave for the development of the first sustainable aircraft "life cycle" service centre in the Shuangliu disctrict,Chengdu, China. This agreement will cover a ...

2022-01-21 15:34 2648

Brand-new Dress-up Game Featuring Characters of Mr. Wasu, "Moving Paper Doll Artist," Released by KYOTOMA on January 5, 2022

TOKYO, Jan. 21, 2022 /PRNewswire/ -- KYOTOMA Inc. (hereinafter "KYOTOMA"), headquartered inTokyo, announced the release of its dress-up game "Soft & Fluffy Dolls 'YURUFUWA'" (iOS / Android) onJanuary 5, 2022. Overview of the game YURUFUWA characters are drawn by a "moving paper doll artist," Mr. ...

2022-01-21 15:00 3924

Aucnet Joins Global Mobility Blockchain Standardization Consortium "MOBI"

TOKYO, Jan. 21, 2022 /PRNewswire/ -- Aucnet Inc. (hereinafter "Aucnet"), based inTokyo, Japan, announced that it has joined the Mobility Open Blockchain Initiative (hereinafter "MOBI") headquartered inLos Angeles in the U.S. state of California, a global nonprofit consortium that develops blockcha...

2022-01-21 14:00 3991

ELEVAI LABS, INC. ANNOUNCES GLOBAL DISTRIBUTION PARTNERSHIP WITH PREMIER AESTHETIC DEVICE COMPANY DERMAPENWORLD

DAVIS, Calif., Jan. 21, 2022 /PRNewswire/ -- ELEVAI LABS, INC., ("ELEVAI" or the "Company") a biotech company leveraging the power of human stem cell exosomes to create next-generation topical skincare products, is pleased to announce that it has signed a non-exclusive global distributor and trad...

2022-01-21 13:41 2269

ECINS Launches Australia Community Support Program Awarding $500,000 (AUD) in Free Services & Subscriptions to Indigenous Organisations and Educational Institutions

>> ECINS Australia Offers Collaborative Case Management Software to Empower Indigenous Organisations & Educational Institutions to Streamline Processes in Order to Meet Exploding Demands DUNSBOROUGH, Australia, Jan. 21, 2022 /PRNewswire/ -- ECINS Australia, the global provider of multi-agency ca...

2022-01-21 08:59 2546

Zendure Welcomes Jim Haflinger as Chief Technical Advisor

PALO ALTO, Calif., Jan. 20, 2022 /PRNewswire/ -- Zendure USA Inc. today announced that it has hiredJim Haflinger to the role of Chief Technical Advisor. As the Silicon Valley portable charger company expands into the sustainable energy sector, Haflinger will lend his decades of electrical engine...

2022-01-21 01:00 2949

10th Award Ceremony for Yiwugo Top Ten Vendors Takes Place Both Online and Offline

YIWU, China, Jan. 20, 2022 /PRNewswire/ -- Yiwugo.com, the official website of the Yiwu Commodity Market, which is the largest commodity wholesale market in the world, held the 2021 Award Ceremony for Yiwugo Top Ten Vendors at Yiwu Marriott Hotel onJanuary 19. The ceremony, which was held online ...

2022-01-21 00:00 3437

StradVision Announces New North American Headquarters in Michigan, Expands Business in U.S.

STERLING HEIGHTS, Mich., Jan. 20, 2022 /PRNewswire/ -- StradVision , an AI-based vision processing technology company for Autonomous Vehicles and ADAS systems, announced today that it has established a North American Headquarters inMichigan, allowing them to better deve...

2022-01-20 23:00 3349

Shoplazza Completes C1 Financing of $150 Million with its Advanced Technology and Global Popularity

TORONTO, Jan. 20, 2022 /PRNewswire/ -- Shoplazza ("the Company"), a leading global e-commerce Software as a Service (SaaS) platform, announced the closing of its$150 million Series C1 financing. The inv...

2022-01-20 23:00 2781

HanAll Biopharma Reports Full-Year 2021 Results and Provides Business Update

* 2021 sales of KRW 101.6 billion for a 15% increase from 2020 * 2021 operating profit of KRW 10.1 billion grew by 70% from 2020 * Increasing milestone payments and revenues from R&D activities are reinvested into new R&D programs SEOUL, South Korea, Jan. 20, 2022 /PRNewswire/ -- [Busines...

2022-01-20 22:00 2979

China.org.cn: 4,700 km of free chauffeuring: A warm story about Xinjiang

BEIJING, Jan. 20, 2022 /PRNewswire/ -- A news report by China.org.cn on two Xinjiang truck drivers' "free chauffeuring":   "To Mansur Patar, Mamat Nurdun: Thank you for so kindly helping out a resident from Peixian county. Our highest tribute to you! This10,000 yuan is a gestur...

2022-01-20 22:00 2561

China Finance Online Co. Ltd. Receives Notice of Delisting from Nasdaq

BEIJING, Jan. 20, 2022 /PRNewswire/ -- China Finance Online Co. Limited ("China Finance Online", or the "Company", "we", "us" or "our") (NASDAQ: JRJC), a leading web-based financial services company that provides Chinese individual investors with fintech-powered online access to securities tradin...

2022-01-20 21:50 5840

Volition presents study data at ASCO GI 2022 on circulating nucleosomes for the detection of colorectal cancer and high-risk advanced adenomas

AUSTIN, Texas, Jan. 20, 2022 /PRNewswire/ --VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has announced the results of two large scale clinical studies, which show that the company's Nu.Q® assays, when used in conjunction with the Fecal Immunochemica...

2022-01-20 21:30 4209

WiMi HoloAR Lens Approved by the Federal Communications Commission to Enter the U.S. Market

BEIJING, Jan. 20, 2022 /PRNewswire/ -- WiMi Hologram Cloud Inc. (Nasdaq: WIMI) ("WiMi" or the "Company"), a leading holographic AR application technology provider in global, today announced that its Augmented reality (AR) head-mounted display (HMD) product for the consumer market, "WIMI HoloAR Le...

2022-01-20 21:05 3047

Euro Tech Holdings Company Limited Announces Appointment of David YL Leung as Chief Executive Officer

HONG KONG, Jan. 20, 2022 /PRNewswire/ -- Euro Tech Holdings Company Limited (NASDAQ: CLWT) (the "Company") announced today that effectiveFebruary 1, 2022, David YL Leung, currently a Director of the Company, will assume the role of Chief Executive Officer ("CEO") of the Company. TC Leung, the Com...

2022-01-20 21:00 4680

I'mbesideyou Inc. SELECTED AS FINALIST FOR 2022 SXSW PITCH

TOKYO, Jan. 20, 2022 /PRNewswire/ -- I'mbesideyou Inc., the startup founded for healing the pain of COVID-19 was selected as a finalist in the Future of Work category for the 14th annual  SXSW Pitch® (formerly SXSW Accelerator). The SXSW P...

2022-01-20 21:00 2309

Hinova Announces First Patient Dosed in a Phase I Clinical Trial of HP518, an Orally Bioavailable Chimeric Degrader Targeting Androgen Receptor for Prostate Cancer Treatment

MELBOURNE, Australia, Jan. 20, 2022 /PRNewswire/ -- Hinova Pharmaceuticals Inc., a clinical-stage biopharmaceutical company focused on developing novel therapeutics for cancers and metabolic diseases through targeted protein degradation technologies, today announced that the first patient with m...

2022-01-20 20:28 2614

Senhwa's Silmitasertib Receives US FDA Orphan Drug Designation for the Treatment of Biliary Tract Cancer

TAIPEI and SAN DIEGO, Jan. 20, 2022 /PRNewswire/ -- Senhwa Biosciences, Inc. (TPEx: 6492), a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and novel coronaviruses, announced that the US Food and Drug Administration (FDA) has granted Orphan Drug Des...

2022-01-20 20:00 3040